Sarfaraz Niazi – författare
Visar alla böcker från författaren Sarfaraz Niazi. Handla med fri frakt och snabb leverans.
6 produkter
Cell Free Synthesis of Biologics
A Comprehensive Guide
Häftad, 2026
2095 kr
Lägg i varukorg
Cell Free Synthesis of Biologics: A Comprehensive Guide addresses the need for efficient production methods in biopharmaceutical manufacturing. As the demand for biologics continues to rise, traditional cell-based production systems often fall short due to high costs and complexity. This book …
Cell Free Synthesis of Biologics
A Comprehensive Guide
E-bok, 2026
2594 kr
Lägg i varukorg
Cell Free Synthesis of Biologics: A Comprehensive Guide addresses the need for efficient production methods in biopharmaceutical manufacturing. As the demand for biologics continues to rise, traditional cell-based production systems often fall short due to high costs and complexity. This book …
Handbook of Biological Therapeutic Proteins
Regulatory, Manufacturing, Testing, and Patent Issues
E-bok, 2024
1052 kr
Lägg i varukorg
Since 1972, which marks the invention of recombinant engineering, more than 500 therapeutic proteins have been approved for clinical use. Today, biological drugs constitute almost 70% of all new drugs and have a biological origin. The first edition of this book dealt with biosimilars, and this …
Handbook of Biological Therapeutic Proteins
Regulatory, Manufacturing, Testing, and Patent Issues
E-bok, 2024
1052 kr
Lägg i varukorg
Since 1972, which marks the invention of recombinant engineering, more than 500 therapeutic proteins have been approved for clinical use. Today, biological drugs constitute almost 70% of all new drugs and have a biological origin. The first edition of this book dealt with biosimilars, and this …
Handbook of Biogeneric Therapeutic Proteins
Regulatory, Manufacturing, Testing, and Patent Issues
Inbunden, 2024
2820 kr
Lägg i varukorg
Since 1972, which marks the invention of recombinant engineering, more than 500 therapeutic proteins have been approved for clinical use. Today, biological drugs constitute almost 70% of all new drugs and have a biological origin. The first edition of this book dealt with biosimilars, and this …
Handbook of Biogeneric Therapeutic Proteins
Regulatory, Manufacturing, Testing, and Patent Issues
Häftad, 2025
890 kr
Lägg i varukorg
Since 1972 when recombinant engineering was invented, over 500 therapeutic proteins have been approved. Today, biological drugs constitute almost 70% of all new drugs and are of biological origin. The first edition of this book dealt with biosimilars, the second focuses on new drugs yet limits to …
